MARKET WIRE NEWS

Emergent BioSolutions Inc. (EBS) Q2 2025 Earnings Call Transcript

Source: SeekingAlpha

2025-08-07 19:31:54 ET

Emergent BioSolutions Inc. (EBS)

Q2 2025 Earnings Conference Call

August 06, 2025, 5:00 PM ET

Company Participants

Joseph C. Papa - CEO, President & Director

Richard S. Lindahl - Executive VP, CFO & Treasurer

Conference Call Participants

Eduardo Rafael Martinez-Montes - H.C. Wainwright & Co, LLC, Research Division

Jessica Macomber Fye - JPMorgan Chase & Co, Research Division

Presentation

Operator

Good afternoon, everyone. Thank you for joining today as Emergent discusses their operational and financial results for the Second Quarter of 2025.

As is customary, today's call is open to all participants. The call is being recorded and is copyrighted by Emergent BioSolutions. In addition to today's press release, there are a series of slides accompanying this webcast available to all webcast participants....

Read the full article on Seeking Alpha

For further details see:

Emergent BioSolutions Inc. (EBS) Q2 2025 Earnings Call Transcript
Emergent Biosolutions Inc.

NASDAQ: EBS

EBS Trading

-1.31% G/L:

$8.30 Last:

154,342 Volume:

$8.26 Open:

mwn-ir Ad 300

EBS Latest News

EBS Stock Data

$592,950,394
50,839,325
1.42%
58
N/A
Pharmaceuticals
Healthcare
US
Gaithersburg

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App